Nuclear size, shape, and density in endometrial carcinoma: Relationship to survival at over 5 years of follow-up. Does analyzing only cells occupying the G0-G1 peak add useful information?

International Journal of Gynecological Cancer

Volumn 14, Issue 1, 2004, Pages 138-144

  Miller, J ^a   Geisler, John P ^a,b   Manahan, K J ^a   Geisler, H E ^a   Miller, G A ^a   Zhou, Z ^a   Wiemann, M C ^a   Crabtree, W ^a  

^a St Vincent Hospitals and Health Services   (United States)

^b Indiana Gynecologic Oncology   (United States)

Author keywords

Endometrial cancer; Nuclear morphometry; Survival

Indexed keywords

ADULT; AGED; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL SIZE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, ADENOSQUAMOUS; CELL NUCLEUS; CYSTADENOCARCINOMA, PAPILLARY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDIANA; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 1442274990     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891x.2004.14031.x     Document Type: Review

References (34)

1. Norris HJ, Becker RL, Mikel UV. A comparative morphometric and cytophotometric study of endometrial hyperplasia, atypical hyperplasia, and endometrial carcinoma. Hum Pathol 1989;20:219-23.
2. Dunton CJ, Baak JP, Palazzo JP, van Diest PJ, McHugh M, Widra EA. Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistant cancer. Am J Obstet Gynecol 1996;174:1518-21.
3. Creasman ET & Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1972;110:773-81.
4. Hanson MB, Van Nagell JR, Powell DE et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 1985;55:1753-7.
5. Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB. Endometrial carcinoma: a multiparameter clinicopathologic analysis including the DNA profile and the sex steroid status. Cancer 1986;58:1518-25.
6. Iverson OE. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 1986;155:770-6.
7. Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC. DNA ploidy in endometrial carcinoma: major objective prognostic factor. Mayo Clin Proc 1990;65:643-50.
8. Newbury R, Schuerch C, Goodspeed N, Farming J, Glidewell O, Evans M. DNA content as a prognostic factor in endometrial carcinoma. Obstet Gynecol 1990;76: 251-7.
9. Moberger B, Auer G, Forsslund G, Moberger G. The prognostic significance of DNA measurements in endometrial carcinoma. Cytometry 1984;5:430-6.
10. Sorbe B, Risberg B, Thornthwaite J. Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma. Int J Gynecol Cancer 1994;4:94-100.
11. Geisler JP, Zhou Z, Miller GA, Wiemann MC, Geisler HE. DNA index by image analysis in advanced endometrial carcinoma. J Surg Oncol 1996;63:91-4.
12. Atkin B. Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus. JNCI 1976;56:909-10.
13. Geisler JP, Wiemann MC, Zhou Z, Miller GA, Geisler HE. A difference in nuclear morphometry when frozen rather than fresh tissue is studied. Eur J Gynaecol Oncol 1997;18:471-3.
14. Geisler JP, Geisler HE, Wiemann MC, Zhou Z, Miller GA. The effect of fixation on the size, shape and summed optical density of endometrial cancer nuclei. Eur J Gynaecol Oncol 1998;19:225-8.
15. Geisler JP, Zhou Z, Miller GA, Wiemann MC, Geisler HE. Markov texture parameters as prognostic indicators in endometrial cancer. Gynecol Oncol 1996;62:174-80.
16. Baak JPA, Kurver PHJ, Overdiep SH et al. Quantitative microscopical, computer aided diagnosis of endometrial hyperplasia or carcinoma in individual patients. Histopathology 1981;5:689-95.
17. Tezuka F, Chiba R, Tkahashi T. Morphometric and multivariate statistical detection of cancer cells in endometrial cytology. Anal Quant Cytol Histol 1994;16: 332-8.
18. Baak JP. The principles and advances of quantitative pathology. Anal Quant Cytol Histol 1994;9:89-95.
19. Geisler JP, Zhou Z, Miller GA, Weimann MC, Geisler HE. Nuclear size, shape, and summed optical density in endometrial cancer. Int J Gynecol Cancer 1997;7:139-43.
20. Mendelsohn ML, Mayall BH. Chromosome identification by image analysis and quantitative cytochemistry. In: Junis JJ, ed. Human Chromosome Methodology, 2nd edn. New York: Academic Press; 1974: 311-46.
21. Bacus JW, Grace LJ. Microscope system for standardized cell measurements and analyses. Appl Opt 1987;26: 3280-93.
22. Geisler JP, Geisler HE, Tammela JE et al. Molecular biologic markers in ovarian carcinoma. CME J Gynecol Oncol 1999;4:210-4.
23. Geisler JP, Wiemann MC, Miller GA, Zhou Z, Geisler HE. Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary. Gynecol Oncol 1996;60:424-7.
24. Geisler JP, Miller GA, Wiemann MC, Geisler HE. Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary. J Surg Oncol 1995;59:45-7.
25. Pressman NJ. Markovian analysis of cervical cell images. J Histochem Cytochem 1976;24:138-44.
26. Russack V. Image cytometry: current applications and future trend. Crit Rev Clin Lab Sci 1994;31:1-34.
27. Weger AR, Lindholm J, Glaser K, Mairinger T, Mikuz G. Morphometry and prognosis in cancer of the pancreatic head. Pathol Res Pract 1992;188:764-9.
28. Epstein JI, Berry SJ, Eggleston JC. Nuclear roundness factor: a predictor of progression in the untreated stage A2 prostate cancer. Cancer 1984;54:1666-71.
29. Miller B, Umpierre S, Tornos C, Burke T. Histologic characterization of uterine papillary serous adenocarcinomas. Gynecol Oncol 1995;56:425-9.
30. Geisler JP, Geisler HE, Wiemann MC, Givens SS, Zhou Z, Miller GA. Nuclear shape: an independent predictor of survival in patients with ovarian carcinoma. Int J Gynecol Cancer 1998;8:164-7.
31. Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z, Crabtree W. Markov optical texture parameters as prognostic indicators in ovarian carcinoma. Int J Gynecol Cancer 1999;9:317-21.
32. Ausems EW, van der Kamp JK, Baak JP. Nuclear morphometry in the determination of the prognosis of marked atypical endometrial hyperplasia. Int J Gynecol Pathol 1985;4:180-5.
33. Baak JP, Langley FA, Talerman A, Delemarre JF. The prognostic variability of ovarian tumor grading by different pathologists. Gynecol Oncol 1987;27:166-72.
34. Baak JP. The use and disuse of morphometry in the diagnosis of endometrial hyplerplasia and carcinoma. Pathol Res Pract 1984;179:20-3.